Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000865491 | SCV001006469 | likely benign | Hereditary spastic paraplegia 49 | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000865491 | SCV001460237 | likely benign | Hereditary spastic paraplegia 49 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003928380 | SCV004745459 | likely benign | TECPR2-related disorder | 2019-09-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |